Published in
American Society for Microbiology, Microbiology Spectrum, 3(11), 2023
DOI: 10.1128/spectrum.04311-22
Links
Tools
A Multicenter Randomized Controlled Trial To Evaluate the Efficacy and Safety of Nelfinavir in Patients with Mild COVID-19
Journal article published in 2023 by
Taiga Miyazaki 
,
Naoki Hosogaya,
Yuri Fukushige,
Sachiko Takemori,
Shinpei Morimoto,
Hiroshi Yamamoto,
Makoto Hori,
Yoshihito Ozawa,
Yuki Shiko,
Yosuke Inaba,
Tomoya Kurokawa,
Hideki Hanaoka,
Shoya Iwanami ,
Kwangsu Kim,
Shingo Iwami
and other authors.
,
Naoki Hosogaya,
Yuri Fukushige,
Sachiko Takemori,
Shinpei Morimoto,
Hiroshi Yamamoto,
Makoto Hori,
Yoshihito Ozawa,
Yuki Shiko,
Yosuke Inaba,
Tomoya Kurokawa,
Hideki Hanaoka,
Shoya Iwanami ,
Kwangsu Kim,
Shingo Iwami
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
The anti-HIV drug nelfinavir suppresses the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in vitro . However, its efficacy in patients with COVID-19 has not been studied.